מונטהלוקאסט טבע ® 5 מ"ג

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

MONTELUKAST AS SODIUM 5 MG

Mevcut itibaren:

TEVA PHARMACEUTICAL INDUST.LTD

ATC kodu:

R03DC03

Farmasötik formu:

CHEWABLE TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Terapötik grubu:

MONTELUKAST

Terapötik endikasyonlar:

Montelukast Teva is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.Montelukast Teva is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Teva and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Teva is indicated for the relief of symptoms of seasonal allergic rhinitis in pediatric patients 6 to 14 years of age and older.

Yetkilendirme tarihi:

2009-04-01